Abbott Laboratories (NYSE:ABT) Upgraded to Buy from Hold
Abbott Laboratories (NYSE:ABT) received an upgrade by equity research analysts at Jefferies & Co Monday morning from Hold to Buy. Jefferies & Co also set a USD55.000 target price per…
Abbot Laboratories (NYSE:ABT) Gets Lower Price Target
BMO Capital Markets has lowered the price target for Abbot Laboratories (NYSE:ABT) to US$48.00 from US$56.00 a share before Monday’s market opening. Abbott Laboratories (NYSE:ABT) is also Reiterated by RBC…